How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Eric Schmidt and other AI leaders (Karpathy, Musk, Anthropic executives) have described recursive self-improvement (RSI)—AI ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
Large language models appear aligned, yet harmful pretraining knowledge persists as latent patterns. Here, the authors prove current alignment creates only local safety regions, leaving global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results